PMN – promis neurosciences inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PMN

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/25

08:00 am

pmn

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

Medium Report

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

Report

3/18

08:07 am

pmn

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD™) [Yahoo! Finance]

High Report

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD™) [Yahoo! Finance]

Report

3/18

08:00 am

pmn

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)

High Report

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)

Report

2/14

01:32 am

pmn

Promis Neurosciences (NASDAQ:PMN) was downgraded by analysts at Wall Stre

Medium Report

Promis Neurosciences (NASDAQ:PMN) was downgraded by analysts at Wall Stre

Report

2/6

10:34 am

pmn

Promis Neurosciences (NASDAQ:PMN) had its price target lowered by analysts at Guggenheim from $125.00 to $35.00. They now have a "buy" rating on the stock.

Low Report

Promis Neurosciences (NASDAQ:PMN) had its price target lowered by analysts at Guggenheim from $125.00 to $35.00. They now have a "buy" rating on the stock.

Report

2/4

05:28 pm

pmn

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Canadian Business Journal (Canada)]

High Report

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Canadian Business Journal (Canada)]

Report

2/4

04:05 pm

pmn

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

High Report

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Report

1/30

08:00 am

pmn

ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing

High Report

ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.